Xiel Limited has been acquired by MIS Healthcare
December 2024 — MIS Healthcare, a leading distributor in medical imaging, has successfully acquired Xiel Limited. This strategic acquisition merges MIS Healthcare’s extensive radiotherapy portfolio with Xiel’s specialized expertise in nuclear medicine, radiotherapy and diagnostic radiology. The merger strengthens both companies’ positions in the rapidly growing fields of oncology and nuclear medicine, promising to deliver exceptional value to the healthcare community in the UK and Ireland.
Xiel Limited is a specialist in nuclear medicine and radiotherapy, serving the UK and Irish markets. The company primarily provides nuclear medicine and radiotherapy capital and services to hospitals, universities, research institutes and private companies, tailoring their offerings to meet specific customer needs.
MIS Healthcare is a UK-based exclusive distributor for world-leading medical manufacturers offering state-of-the-art products, including high-end medical imaging diagnostic equipment, PACS/RIS, medical consumables and diagnostic instruments. The company aims to become a leading specialist in the diagnostic imaging, radiology and oncology markets.
Our role in the transaction
Oaklins S&W, one of Oaklins’ member firms in the UK, served as the corporate finance advisor to the shareholders of Xiel Limited.
Talk to the deal team
Related deals
Terhills Resort by Center Parcs has been acquired by TwentyTwo Real Estate
Terhills Resort, a premium resort in Belgium combining luxury and nature located near Hoge Kempen National Park and operated by Center Parcs, has been sold by venture capitalist LRM to TwentyTwo Real Estate, an independent real estate investor and operator. Both the real estate and the operations were included in the transaction, and Center Parcs is staying on board as an operational partner.
Learn moreBolster Investment Partners has secured debt financing for the acquisition of Royal Taste Company
Bolster Investment Partners has partnered with Royal Taste Company, a leading Dutch custom signature coffee platform offering end-to-end sourcing, blending, roasting, packaging and delivery services. The partnership marks an important next step in Royal Taste Company’s growth trajectory, focused on further geographical expansion, commercial development and selective strategic acquisitions.
Learn moreUKAT Group has acquired Bayberry Limited
UK Addiction Treatment (UKAT) Group, a leading UK provider of residential addiction, mental health and behavioral health treatment backed by Sullivan Street Partners, has acquired Bayberry Limited, a specialist mental health and wellbeing treatment provider. Joining UKAT enables Bayberry to preserve continuity of care for patients and referral partners, retain the strength of its clinical team and benefit from UKAT’s operational infrastructure, referral network and marketing channels. This partnership supports Bayberry’s next stage of development while preserving the qualities that differentiate its service offering.
Learn more